Press Release


Clinical Neurosciences Journal

Clinical Neurosciences is established to promote the knowledge of the neurological sciences and their clinical application. We aim to communicate the peer-reviewed research in the field of clinical neurosciences. We are a platform for scientific discourse and the public health advocacy.

Browse the journal, submit your manuscript and see more information on the journal’s website

The journal welcomes negative results, publishes all articles on an open-access basis and does not charge any fees for publication or browsing.



Read More

Prof Jerzy Vetulani Awarded an Honorary Fellowship

The Prefect and the Convocation House of the Oxford Neurological Society, upon application of the Fellow for Honours, decided to confer the award of the Honorary Fellowship on prof Jerzy Adam Gracjan Vetulani, a distinguished neuropsychobiologist affiliated with the Jagiellonian University in Cracow and the Institute of Pharmacology of the Polish Academy of Sciences.


Read More

Thank you and farewell – Interview with departing president

Mr Schpackenbaum, first of all, let me thank you for agreeing to this interview, especially given your tight schedule. You are a very experienced member of the Society, and you have seen it evolving across many years. What was the most prominent change?

Christopher Schpackenbaum, FNS (CS): If I were to compare the Society now, in 2016, to what it was in 1956, it is actually not that different at all! The world has changed immensely, but because the society was always designed to keep up with the change, challenge the status quo and be very sceptical to the current state of mind, it managed to secure its freshness of mind and scientific reasoning. I appreciate the average age of our distinguished House has quite deteriorated since Coronation, but just as Her Majesty, we are doing very well indeed!

With the advent of the ICT, social media and computerised health service, we faced major challenges. Not all of us could easily modernise to the paperless communication, publishing on the websites or setting up Twitter accounts. I guess we still need some major improvement in these areas. I cannot emphasise it enough, however, that the world outside the Net does exist! And it is much more interesting and vivid, if you ask me.


Read More

Verdict in the favour of the Prosecution

In the matter of The Current Addiction Model being invalid, we, the Convocation House of the Oxford Neurological Society, hereby announce that the motion is carried.

Thus, the verdict shall be entered in the favour of the Prosecution.

Presiding adjudicator: Christopher Schpackenbaum, FNS

Read the Prosecution’s argument [WON]

Read the Defence argument [DEFEATED]

My learned colleagues, fellow members of the Convocation House – I believe that the Prosecution have proved, beyond reasonable doubt, that the current addition model is indeed invalid.


Read More

Oxford Neurosoc Online

Oxford Neurosoc Online is the new service available to our Members. You can use 30GB of Google Drive space, collaborate with others on Sheets, Docs or Slides, share calendars and group lists, and use Hangouts for calls, chats and streaming.

We will seek to expand this service in the forthcoming months, so please do share your suggestions and indeed any feedback you may have at

Your login will be your email address at If you wish to obtain this address or have any technical problems, please contact us at

The login button will be displayed on the right-hand side of the website, just under the social networking links.



Read More

The Society supports AllTrials Initiative – Sign the petition today!

It’s time all clinical trial results are reported.

Patients, researchers, pharmacists, doctors and regulators everywhere will benefit from publication of clinical trial results. Wherever you are in the world please sign the petition:

Thousands of clinical trials have not reported their results; some have not even been registered.

Information on what was done and what was found in these trials could be lost forever to doctors and researchers, leading to bad treatment decisions, missed opportunities for good medicine, and trials being repeated.

All trials past and present should be registered, and the full methods and the results reported.

We call on governments, regulators and research bodies to implement measures to achieve this.

Sign the petition today and support our common cause. 


Read More